Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Journal of Medicinal Chemistry|March 1, 1989
Long acting dihydropyridine calcium antagonists. 2. 2-[2-Aminoheterocycloethoxy]methyl derivativesJ E Arrowsmith, S F Campbell, P E Cross, et al.Journal of Medicinal Chemistry|June 1, 1990
Long-acting dihydropyridine calcium antagonists. 5. Synthesis and structure-activity relationships for a series of 2-[[(N-substituted-heterocyclyl)ethoxy]methyl]-1,4-dihydropyridine calcium antagonistsD Alker, S F Campbell, P E Cross, et al.Journal of Medicinal Chemistry|October 1, 1989
Long-acting dihydropyridine calcium antagonists. 3. Synthesis and structure-activity relationships for a series of 2-[(heterocyclylmethoxy)methyl] derivativesD Alker, S F Campbell, P E Cross, et al.Journal of Medicinal Chemistry|April 1, 1990
Selective class III antiarrhythmic agents. 1 Bis(arylalkyl)aminesP E Cross, J E Arrowsmith, G N Thomas, et al.Journal of Medicinal Chemistry|February 1, 1990
Long-acting dihydropyridine calcium antagonists. 4. Synthesis and structure-activity relationships for a series of basic and nonbasic derivatives of 2-[(2-aminoethoxy)methyl]-1,4-dihydropyridine calcium antagonistsD Alker, S F Campbell, P E Cross, et al.The Journal of Pharmacology and Experimental Therapeutics|January 1, 1991
UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cellsM Gwilt, J E Arrowsmith, K J Blackburn, et al.Journal of Cardiovascular Pharmacology|March 1, 1991
Electrophysiologic properties of UK-66,914, a novel class III antiarrhythmic agentM Gwilt, H W Dalrymple, R A Burges, et al.Journal of Medicinal Chemistry|February 1, 1980
Cerebrovasodilatation through selective inhibition of the enzyme carbonic anhydrase. 2. Imidazo[2,1-b]thiadiazole and imidazo[2,1-b]thiazolesulfonamidesI T Barnish, P E Cross, R P Dickinson, et al.Journal of Medicinal Chemistry|September 1, 1986
Long-acting dihydropyridine calcium antagonists. 1. 2-Alkoxymethyl derivatives incorporating basic substituentsJ E Arrowsmith, S F Campbell, P E Cross, et al.Journal of Pharmaceutical and Biomedical Analysis|January 1, 1991
Measurement of the class III antidysrhythmic drug, UK-68,798, in plasma by radioimmunoassayD K Walker, G W Aherne, J E Arrowsmith, et al.Pageof 3